Jubilant Organosys has reported a rise of 52.4% in net profit at Rs1191m for the year ended March ’05, compared to the previous year.
The net profits for the pharma company rose by 37.8% to Rs343m with the total revenue standing at Rs3215m. The company recommended 125% dividend for the year on fully paid up equity shares of Rs5 each. The EPS of the company stood at Rs46.77 for the year. Net sales of the company increased by 36.2% to Rs1170m.
A company statement said that the performance in the international market, especially in the regulated market, remained strong where sales contributed 68.5% of international sales, compared to 52.8% in the previous year.
